Comparison of 3 Routes of Administration of Tranexamic Acid on Primary Unilateral Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study

Journal of Arthroplasty

Volumn 32, Issue 9, 2017, Pages 2738-2743

  Yuan, Xiangwei ^a   Li, Bin ^a   Wang, Qiaojie ^a   Zhang, Xianlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

hemoglobin loss; intravenous; oral; topical; total knee arthroplasty; tranexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRAINAGE VOLUME; DRUG COST; ECCHYMOSIS; FAT LIQUEFACTION; FEMALE; HOSPITAL PATIENT; HUMAN; INTRAMUSCULAR VENOUS THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIMARY UNILATERAL TOTAL KNEE ARTHROPLASTY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL INFECTION; THROMBOEMBOLISM; TOTAL KNEE ARTHROPLASTY; TREATMENT OUTCOME; WOUND DEHISCENCE; WOUND DISCHARGE; WOUND HEALING; AGED; ARTHRITIS; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; KNEE; KNEE REPLACEMENT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHRITIS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 85018665134     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2017.03.059     Document Type: Article

References (41)

1. Kurtz, S., Ong, K., Lau, E., Mowat, F., Halpern, M., Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89 (2007), 780–785.
2. Kurtz, S.M., Ong, K.L., Lau, E., Bozic, K.J., Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am 96 (2014), 624–630.
3. Holt, J.B., Miller, B.J., Callaghan, J.J., Clark, C.R., Willenborg, M.D., Noiseux, N.O., Minimizing blood transfusion in total hip and knee arthroplasty through a multimodal approach. J Arthroplasty 31 (2016), 378–382.
4. Bierbaum, B.E., Callaghan, J.J., Galante, J.O., Rubash, H.E., Tooms, R.E., Welch, R.B., An analysis of blood management in patients with a total hip or knee arthroplasty. J Bone Joint Surg Am 81 (1999), 2–10.
5. Kalairajah, Y., Simpson, D., Cossey, A.J., Verrall, G.M., Spriggins, A.J., Blood loss after total knee replacement: effects of computer-assisted surgery. J Bone Joint Surg Br 87 (2005), 1480–1482.
6. Wong, J., Abrishami, A., El Beheiry, H., Mahomed, N.N., Roderick Davey, J., Gandhi, R., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92 (2010), 2503–2513.
7. Spanh, D.R., Cassut, M., Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 93 (2000), 242–255.
8. Pulido, L., Ghanem, E., Joshi, A., Purtill, J.J., Parvizi, J., Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466 (2008), 1710–1715.
9. Carroll, K., Dowsey, M., Choong, P., Peel, T., Risk factors for superficial wound complications in hip and knee arthroplasty. Clin Microbiol Infect 20 (2014), 130–135.
10. Carson, J.L., Duff, A., Poses, R.M., Berlin, J.A., Spence, R.K., Trout, R., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 (1996), 1055–1060.
11. Lasocki, S., Krauspe, R., von Heymann, C., Mezzacasa, A., Chainey, S., Spahn, D.R., PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol 32 (2015), 160–167.
12. Paul, J.E., Ling, E., Lalonde, C., Thabane, L., Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth 54 (2007), 799–810.
13. Hu, S., Zhang, Z.Y., Hua, Y.Q., Li, J., Cai, Z.D., A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br 91 (2009), 935–942.
14. Tai, T.W., Chang, C.W., Lai, K.A., Lin, C.J., Yang, C.Y., Effects of tourniquet use on blood loss and soft-tissue damage in total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 94 (2012), 2209–2215.
15. Alcelik, I., Pollock, R.D., Sukeik, M., Bettany-Saltikov, J., Armstrong, P.M., Fismer, P., A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty 27 (2012), 331–340.
16. Tetro, A.M., Rudan, J.F., The effects of a pneumatic tourniquet on blood loss in total knee arthroplasty. Can J Surg 44 (2001), 33–38.
17. Nielsen, C.S., Jans, Ø., Ørsnes, T., Foss, N.B., Troelsen, A., Husted, H., Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 98 (2016), 835–841.
18. Alshryda, S., Sukeik, M., Sarda, P., Blenkinsopp, J., Haddad, F.S., Mason, J.M., A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 96-B (2014), 1005–1015.
19. Okamoto, S., Hijikata-Okunomiya, A., Wanaka, K., Okada, Y., Okamoto, U., Enzyme controlling medicines: introduction. Semin Thromb Hemost 23 (1997), 493–501.
20. Chen, J.Y., Chin, P.L., Moo, I.H., Pang, H.N., Tay, D.K., Chia, S.L., et al. Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: a double-blinded randomised controlled noninferiority trial. Knee 23 (2016), 152–156.
21. Lin, Z.X., Woolf, S.K., Safety, efficacy, and cost-effectiveness of tranexamic acid in orthopedic surgery. Orthopedics 39 (2016), 119–130.
22. Fillingham, Y.A., Kayupov, E., Plummer, D.R., Moric, M., Gerlinger, T.L., Della Valle, C.J., A randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost?. J Arthroplasty 31:9 Suppl (2016), 26–30.
23. Yang, Z.G., Chen, W.P., Wu, L.D., Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 94 (2012), 1153–1159.
24. Carson, J.L., Terrin, M.L., Noveck, H., Sanders, D.W., Chaitman, B.R., Rhoads, G.G., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365 (2011), 2453–2462.
25. Longstaff, C., Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 5 (1994), 537–542.
26. Gomez-Barrena, E., Ortega-Andreu, M., Padilla-Eguiluz, N.G., Pérez-Chrzanowska, H., Figueredo-Zalve, R., Topical intraarticular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 96 (2014), 1937–1944.
27. Dahl, O.E., The role of the pulmonary circulation in the regulation of coagulation and fibrinolysis in relation to major surgery. J Cardiothorac Vasc Anesth 11 (1997), 322–328.
28. Sukeik, M., Alshryda, S., Haddad, F.S., Mason, J.M., Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93 (2011), 39–46.
29. Su, E.P., Su, S., Strategies for reducing perioperative blood loss in total knee arthroplasty. Bone Joint J 98-B:1 Suppl A (2016), 98–100.
30. Irwin, A., Khan, S.K., Jameson, S.S., Tate, R.C., Copeland, C., Reed, M.R., Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J 95-B (2013), 1556–1561.
31. Nilsson, I.M., Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl 14 (1980), 41–47.
32. Ahlberg, A., Eriksson, O., Kjellman, H., Diffusion of tranexamic acid to the joint. Acta Orthop Scand 47 (1976), 486–488.
33. Patel, V.P., Walsh, M., Sehgal, B., Preston, C., DeWal, H., Di Cesare, P.E., Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 89 (2007), 33–38.
34. Emara, W.M., Moez, K.K., Elkhouly, A.H., Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of postoperative bleeding in hemiarthroplasty. Anesth Essays Res 8 (2014), 48–53.
35. Ridgeway, S., Wilson, J., Charlet, A., Kafatos, G., Pearson, A., Coello, R., Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br 87 (2005), 844–850.
36. Cordero-Ampuero, J., de Dios, M., What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties?. Clin Orthop Relat Res 468 (2010), 3268–3277.
37. Moskal, J.T., Harris, R.N., Capps, S.G., Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. J Arthroplasty 30 (2015), 365–368.
38. Yi, Z., Bin, S., Jing, Y., Zongke, Z., Pengde, K., Fuxing, P., Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg Am 98 (2016), 983–991.
39. Gillette, B.P., Maradit Kremers, H., Duncan, C.M., Smith, H.M., Trousdale, R.T., Pagnano, M.W., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 28:8 Suppl (2013), 137–139.
40. Bauer, K.A., Eriksson, B.I., Lassen, M.R., Turpie, A.G., Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 345 (2001), 1305–1310.
41. Donath, L., Lützner, J., Werth, S., Kuhlisch, E., Hartmann, A., Günther, K.P., et al. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery–findings from the ORTHO-TEP registry. Br J Clin Pharmacol 74 (2012), 947–958.